ClinicalTrials.govpublic full text
A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
carcinoma, hepatocellular, biliary tract cancer, secondary liver cancer, liver metastases, tlr7 agonist, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 885714
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.